ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 310

Differential Expression of microRNA in Monocytes from Children with Systemic Juvenile Idiopathic Arthritis: Implications for Polarized Phenotype

Grant Schulert1, Ndate Fall2, Nan Shen3 and Alexei Grom4, 1Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Rheumatology, Shanghai Institutes for Biological Sciences Chinese Academy of Sciences & Shanghai Jiao Tong University School of Medicine, Shanghai, OH, China, 4Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: MAS, MicroRNA, Systemic JIA and monocytes

  • Tweet
  • Email
  • Print
Session Information

Title: Pediatric Rheumatology - Pathogenesis and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose: Systemic juvenile idiopathic arthritis (SJIA) is an autoinflammatory disease of childhood, and the predominant effector cells are mononuclear phagocytes rather than lymphocytes as in autoimmune diseases such as rheumatoid arthritis (RA).  Previous gene expression data has shown that monocytes in SJIA have a novel phenotype with clear proinflammatory activation as well as features of alternative activation.  This aberrant phenotype may contribute to the potential of these children to develop macrophage activation syndrome (MAS).  What controls monocyte/macrophage differentiation in SJIA is unknown.  MicroRNA are small, non-coding RNA that serve as transcriptional negative regulators to fine-tune gene expression programs involved in cell differentiation, metabolism and immunity.  There is growing evidence that miRNA contribute to the pathogenesis of human disease, including RA.  These regulators have also been implicated in controlling differentiation of monocytes and macrophages.  However, miRNA expression in SJIA has not been examined.  Here, we examine miRNA expression profiles in peripheral blood monocytes from children with SJIA.

Methods: We enrolled children with active SJIA, defined as presence of active arthritis or systemic features, as well as those with new-onset disease or clinically inactive disease (CID).  Freshly isolated CD14+ monocytes were isolated by magnetic beads separation, and used to generate RNA which in turn was used to quantitate the expression of 384 miRNA and controls on the TaqMan ™ MicroRNA Array A.

Results: We found that monocyte expression of mir-125a-5p was significantly elevated in children with active SJIA compared to those with CID (relative expression 16.8 vs. 3.0, p<0.05).  In addition, expression of mir-125a-5p was significantly correlated with markers of disease activity including ferritin (R=0.73, p<0.001) as well as presence of systemic features such as hepatosplenomegaly.  Recently miR-125a-5p has been suggested to play an essential role in monocyte polarization.  We also found several specific miRNA with differential expression in monocytes from children with new-onset disease compared to those with active established disease.  One of these, miR-187, has been implicated in negative regulation of inflammatory cytokines including IL-6.  We find that miR-187 expression strongly correlates with markers of disease activity including C-reactive protein (R=0.813, p<0.05), ferritin (R=0.644, p<0.05) and soluble IL-2 receptor (R=0.779, p<0.05) as well as presence of systemic features.  Interestingly, while monocyte expression of miR-146a has been correlated with disease activity in RA, we found no difference in expression between monocytes from patients with active SJIA and those with CID.

Conclusion: These results provide the first report of miRNA expression profiles in children with SJIA.  Taken together, these data suggest that differential miRNA expression contributes to the phenotype of monocyte/macrophages in SJIA, and may have implications for disease pathogenesis and development of MAS.  Further work will examine impact of miRNA expression on monocyte function and differentiation.


Disclosure:

G. Schulert,
None;

N. Fall,
None;

N. Shen,
None;

A. Grom,

NovImmune,

2,

Novartis Pharmaceutical Corporation,

2,

Novartis Pharmaceutical Corporation,

5,

Roche Pharmaceuticals,

5.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/differential-expression-of-microrna-in-monocytes-from-children-with-systemic-juvenile-idiopathic-arthritis-implications-for-polarized-phenotype/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology